Journal
CIRCULATION
Volume 136, Issue 12, Pages 1167-1169Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.117.029529
Keywords
central systolic pressure; empagliflozin; pulse wave analysis; SGLT-2 inhibitor; type 2 diabetes mellitus
Funding
- Boehringer Ingelheim Pharma GmbH Co. KG